Clinical Trials

Anemia with Advanced Stage Non-small Cell Lung Cancer Receiving Multi-Cycle Chemotherapy

Purpose

To demonstrate the overall survival of subjects receiving a single agent for Chemo-Induced Anemia in Stage IV Non-small Cell Lung Cancer patients.

Criteria 

• Male and Female patients at least 18 years of age 
• Confirmed diagnosis of Stage IV Non-small Cell Lung Cancer (not recurrent or re-staged) 
• Expected to receive at least 2 additional cycles of first line myelosuppressive cyclic chemotherapy 
• Requiring a baseline radiographic scan of the chest to assess disease burden before starting on first line chemotherapy  

Details

• Screening Period: up to 21 days 
• Treatment Period: at least 6 total weeks 
• Study visits: every 3 weeks 
• Radiographic imaging: every 9 weeks  

Interested in Volunteering for the Study?

If you would like more information about this study, please call us at (318) 212-8671.